Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants (NCT07512245) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants
United States40 participantsStarted 2026-08
Plain-language summary
This study aims to compare soft tissue grafting with acellular dermis at Phase I or Phase II dental implant surgery.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* English speaking
* At least 18 years old
* Must be a patient of the UAB Dental School
* Able to read and understand informed consent document
* Patients presenting with a single edentulous site planned for dental implant placement deemed deficient in soft tissue peri-implant phenotype (\> 2mm width of keratinized tissue, \< 1mm marginal soft tissue thickness, and/or \> 2mm vertical soft tissue height)
* Presence of periodontally healthy, non-carious neighboring teeth and/or healthy restored dental implants on either side of edentulous site planned for dental implant placement.
* No anticipated need for surgical and/or endodontic care at teeth adjacent to the proposed surgical site during the study period.
Exclusion Criteria:
* Non-English speaking
* Less than 18 years old
* Smokers/tobacco users (\>10 cigarettes/day)
* Patients with systemic pathologies or conditions contraindicating oral surgical procedures or adversely affecting wound healing
* Edentulous sites treatment planned for dental implant placement with adequate implant site soft tissue quality/quantity (\> 2mm width of keratinized tissue, \> 1mm marginal soft tissue thickness, and/or \> 2mm vertical soft tissue height).
* Absence of adjacent teeth/implants on either side of the tooth to be extracted and/or edentulous sites where 2 or more adjacent implants are planned.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Width of buccal keratinized tissue at dental implant sites
Timeframe: From baseline to 6 months
2
Thickness of buccal keratinized tissue 2mm from the gingival margin of the dental implant sites
Timeframe: From baseline to 6 months
3
Vertical height of peri-implant soft tissues
Timeframe: From Baseline to 6 months
4
Radiographic marginal bone loss
Timeframe: From baseline to 6 months
5
Patient centered outcomes using the Visual Analog Scale (VAS)